Search filters

List of works by Brad S. Kahl

BV for HL: can the responses last?

scientific article published in September 2016

Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report

scientific article published in September 2023

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

scientific article published on 01 December 2018

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

scientific article published on 15 December 2016

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

scientific article published on 07 September 2015

Follicular lymphoma: evolving therapeutic strategies

scientific article published on 17 March 2016

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

scientific article published on 26 November 2012

Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

scientific article published in November 2017

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

scientific article published on 23 February 2018

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

scientific article

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

scientific article

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

scientific article

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

scientific article

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

scientific article published on 26 May 2020

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

scientific article

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

scientific article

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

scientific article published on 28 August 2012

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial

scientific article published on 20 April 2015

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

scientific article

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

scientific article published on 17 June 2008

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

scientific article

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

scientific article published on 29 January 2013

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

scientific article

Paulina is supported by:

About Paulina

Help